Abstract
BACKGROUND: Unprecedented demand for N95 respirators during the coronavirus disease 2019 (COVID-19) pandemic has led to a global shortage of these masks. We validated a rapidly applicable, low-cost decontamination protocol in compliance with regulatory standards to enable the safe reuse of N95 respirators.
METHODS: We inoculated 4 common models of N95 respirators with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and evaluated viral inactivation after disinfection for 60 minutes at 70°C and 0% relative humidity. Similarly, we evaluated thermal disinfection at 0% to 70% relative humidity for masks inoculated with Escherichia coli. We assessed masks subjected to multiple cycles of thermal disinfection for structural integrity using scanning electron microscopy and for protective functions using standards of the United States National Institute for Occupational Safety and Health for particle filtration efficiency, breathing resistance and respirator fit.
RESULTS: A single heat treatment rendered SARS-CoV-2 undetectable in all mask samples. Compared with untreated inoculated control masks, E. coli cultures at 24 hours were virtually undetectable from masks treated at 70°C and 50% relative humidity (optical density at 600 nm wavelength, 0.02 ± 0.02 v. 2.77 ± 0.09, p < 0.001), but contamination persisted for masks treated at lower relative humidity. After 10 disinfection cycles, masks maintained fibre diameters similar to untreated masks and continued to meet standards for fit, filtration efficiency and breathing resistance.
INTERPRETATION: Thermal disinfection successfully decontaminated N95 respirators without impairing structural integrity or function. This process could be used in hospitals and long-term care facilities with commonly available equipment to mitigate the depletion of N95 masks.
As the coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many health care systems worldwide, the unprecedented demand for personal protective equipment (PPE) has exhausted stockpiles and interrupted global supply chains for N95 respirators. Currently, the proportion of frontline health care workers among individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exceeds 10% in some regions and is expected to increase if PPE stockpiles diminish further.1,2 As a result, protecting front-line workers from SARS-CoV-2 infection is now an immediate global concern.3
Disposable N95 respirators protect users against infectious airborne particles and are therefore critical to front-line workers during the COVID-19 pandemic.3 However, the present global shortage of PPE has forced regulating institutions to adjust infection control measures. Before the pandemic, guidelines recommended disposal of N95 respirators after each patient encounter. Now, evolving guidelines instruct staff to reuse 1 mask over their whole shift, or even longer.4 This policy of reusing disposable masks in the setting of high airborne pathogen exposure — such as aerosol-generating medical procedures in the care of patients with COVID-19 — may result in accumulation of contagious material on the mask surface, risking the health and safety of personnel and patients.5,6 Inactivating accumulated pathogens in disposable respirators without affecting the respirators’ protective properties may enable safe reuse and thus help to alleviate the current global shortage temporarily. However, the sterilization methods regularly used in health care institutions potentially degrade disposable respirators and thereby affect fit or filtration efficiency.7
Thermal disinfection may overcome this issue and provide a widely available and cost-effective decontamination strategy for disposable respirators. Recent reports show a high sensitivity to heat for SARS-CoV-2, as 5 minutes of heating at 70°C inactivates the virus.5,8 The polypropylene microfibres in commercially available N95 respirators have a thermal degradation point above 130°C, suggesting that the filter may withstand repetitive exposure to 70°C.9,10 However, the viricidal efficacy of thermal disinfection for N95 respirators contaminated with SARS-CoV-2, and the protective performance of heat-treated respirators, have not been validated to a level meeting regulatory standards in the United States.
We therefore investigated whether thermal disinfection at 70°C for 60 minutes inactivates pathogens, including SARS-CoV-2, while maintaining critical protective properties of N95 respirators for multiple cycles of disinfection and reuse in a real-world setting.
Methods
Thermal disinfection protocol for N95 respirators
We used thermal disinfection in cycles of 60 minutes at 70°C, at either 0% or 50% relative humidity, to treat 4 common models of commercially available N95 respirators (8110s, 9105s, 8210 and 1860s; 3M). We wrapped the respirators in sterilization pouches (Steril-Peel, GS Medical Packaging) before disinfection. To control for temperature and relative humidity, we set the BevLes Heated Holding Cabinet with humidity (BevLes Inc.) to 70°C and varied the humidity between 0% and 50% relative humidity. We used a digital thermo- and hygrometer (Hagen Group Inc., Canada) as an added quality-control measure. Additionally, we accounted for potential real-world temperature fluctuations by cooling the masks to room temperature for 5 minutes mid-cycle.
Inactivation of SARS-CoV-2
We assessed inactivation of SARS-CoV-2 in all 4 N95 respirator models. We cut unprocessed and 10× heat-treated N95 respirators into 1 cm2 pieces and inoculated the outer surface of the respirators with 5 μL of SARS-CoV-2 (about 7.8 log 50% tissue culture infective dose per mL [TCID50/mL]) in triplicates (n = 3 per respirator type) in a biosafety level 3 laboratory. The virus-inoculated respirators underwent thermal disinfection at 70°C at 0% relative humidity for 60 minutes, with and without a 5-minute cool-down mid cycle, followed by soaking in 300 μL of viral transport medium for 30 minutes for virus elution. We then titrated the recovered infectious virus particles by standard TCID50 assay, using Vero E6 cells as described.5 We used virus-inoculated respirator surfaces without the heat inactivation step as controls.
Bacterial inactivation
To test for bacterial inactivation, we cut unprocessed N95 respirators (1860S; 3M) into 1 cm2 pieces. We inoculated the outer surface with 100 μL of Escherichia coli (4 × 108 colony-forming units [CFU] per mL, optical density 0.612 at 600 nm) and inoculated a negative control with pure Luria–Bertani medium. The inoculated respirators underwent 60 minutes of heat treatment at 70°C at either 0%, 25% relative humidity, 40% relative humidity, or 50% relative humidity (n = 4 per condition). We treated a high-temperature control sample at 90°C/70% relative humidity and left a positive, E. coli–inoculated control at room temperature for 1 hour. We then washed N95 fragments individually in 1 mL of Luria–Bertani medium and inoculated 100 μL washing media on Luria–Bertani agar plates. We counted colonies after 24 hours of incubation at 37°C (Figure 1). To the 900 μL of remaining washing media and N95 fragments, we added 9.1 mL Luria–Bertani media and incubated it at 37°C in a shaking incubator. We read optical density at 600 nm (Epoch Microplate Spectrophotometer, BioTek) after 24 hours of incubation to estimate bacteria concentration.
Microstructural analysis of the N95 filter layer
To assess whether exposing the polymer microfibres of the N95 filter media to high temperatures caused fibre degradation, we analyzed a 1 cm2 filter sample from unprocessed respirators and respirators that underwent 10 thermal disinfection cycles at 70°C and 0% relative humidity, or 50% relative humidity. We coated each sample with 10 nm of carbon and imaged them with a scanning electron microscope (XL30, FEI) at magnifications of ×150, ×200, ×650 and ×1200 at 5 keV. We analyzed fibre morphology with a blinded observer using ImageJ (https://imagej.nih.gov/ij/) in 10 randomly selected individual fibres from all quadrants of a representative image of each sample. We measured the fibre diameters in 40 individual fibres per condition (10 fibres per mask type) to calculate the mean fibre diameter after each disinfection cycle.
Quantitative N95 respirator fit testing
Exposure to high temperatures may affect the mechanical properties of the respirator components, such as elasticity of the headbands or adjustability of the nose clip, potentially allowing for leakage of particles. To test the respirator fit, we applied a standardized, quantitative fit testing procedure in a total of 46 respirators (n = 12 per type, except n = 10 for 1860s) using a PortaCount Pro+ Respirator Fit Tester 8038 (TSI Incorporated) and a particle generator model 8026 (TSI Incorporated) in compliance with governmental regulatory guidelines (the United Kingdom Health and Safety Executive, US Occupational Safety and Health Administration [OSHA] and Canadian Standards Association [CSA]).11–13 Particles greater than 0.02 μm in size were detected in a concentration range of 0.01 to 2.5 × 105 particles/cm3. We measured average ambient and in-mask particle concentration during standardized exercises and calculated their ratio as the respirator fit factor, with a fit factor of 100 being defined by the OSHA as the minimum pass value.11 Fitted respirators were personalized to 2 blinded test participants (1 male, 1 female) and underwent thermal disinfection at 0% or 50% relative humidity, respectively (n = 23 each), as outlined above. After 5, 10 and 15 disinfection cycles, we repeated the quantitative fit testing for each respirator, with the same test participant. Additionally, the blinded test participant rated the subjective fit, adjustability and comfort of each decontaminated respirator compared with the unprocessed reference masks, according to the CSA Comfort Assessment Score (0 — no issues; 1 — discomfort can be ignored; 2 — some discomfort but still able to function; 4 — unacceptable discomfort).13
N95 filter efficiency and breathing resistance testing
We determined the breathing resistance and particulate filter efficiency in n = 12 unprocessed masks and in a total of n = 58 N95 respirators that underwent either 5 or 10 cycles of thermal disinfection at 0% or 50% relative humidity, using the abbreviated National Institute for Occupational Safety and Health (NIOSH) standard.14–16 To measure breathing resistance, we mounted the respirators on a test fixture with air flowing at a rate of 85 ± 2 L/min. In accordance with the NIOSH standard, a breathing resistance below 343.23 Pa is considered tolerable.16 For NIOSH filtration efficiency protocols, we preconditioned the respirators at 85 ± 5% relative humidity and 38 ± 2.5°C for 25 ± 1 hour and then mounted them on a certified condensation particle counter (model 3772, TSI Incorporated). We tested the respirators against a near monodispersed polystyrene latex bead at a flow rate of 85 ± 2 L/min, at 21–26°C and 30.4%–43.2% relative humidity. We calculated particle filter efficiency as the percentage of all counted particles (median diameter 0.075 ± 0.020 μm) removed by the respirator. For N95 masks, particle filter efficiency must be equal to or greater than 95%.15
Statistical analysis
We conducted statistical analyses using JMP (version 15.1.0; SAS Institute). We calculated descriptive statistics among all tested respirators for each condition. All means are expressed with standard deviation (± SD). Given the limited sample size owing to the global shortage of N95 respirators, we used 1-sample t tests to compare the group means of the disinfected masks to the respective US-regulatory pass value for each assessment. Sample size calculations for quantitative respirator fit showed a required sample size of n = 12 to detect a mean fit factor of 120 (pass value 100, mean fit factor of unprocessed mask 190 ± 15) on an α level of 0.01 and a power of 0.95.17 We chose an α level of 0.01 for 1-sided p values to increase the stringency and adjust for multiple comparisons. Additionally, we assumed US-regulatory compliance of the disinfected masks only when the lower bound of the 99% confidence intervals (CIs) was greater than the minimum required pass value. See Table 1 for further details on the experimental design and statistical methods used.
Results
Inactivation of SARS-CoV-2
After dry heat treatment (70°C for 60 min), no infectious SARS-CoV-2 could be detected in any of the previously virus-inoculated respirators, whereas high levels of SARS-CoV-2 could still be detected in respirators that had not undergone heat treatment (Table 2).
Bacterial inactivation
No E. coli could be detected in inoculated N95-respirators when heat treated for 60 minutes at 70°C at 50% relative humidity or at 90°C at 70% relative humidity. As shown in Figure 1, in samples exposed to dry heat (70°C/0% relative humidity), more than 1000 bacterial colonies were still detectable, while exposure to 70°C with humidity (25% and 40% relative humidity) dramatically reduced colony formation. Consequently, thermal disinfection for 60 minutes at 70°C and 50% relative humidity eliminated E. coli contamination on N95 respirators (Table 3, Figure 1).
Structural properties of the N95 filter
We analyzed the N95 filter media in new, unprocessed (control) respirators and observed an overall mean fibre diameter of 3.88 ± 2 μm. Even after 10 cycles of thermal disinfection of 60 minutes at 70°C at either 0% or 50% relative humidity, the mean overall fibre diameter remained within the range for unprocessed N95 filters as specified in the US patent (Figure 2).9
Respirator function
We conducted quantitative fit testing with 4 common types of commercially available N95 respirators that underwent 5, 10 and then 15 cycles of thermal disinfection at 0% and 50% relative humidity, respectively (n = 23 for each condition; Figure 3). All tested groups of thermally disinfected respirators significantly exceeded the fit factor of 100, the OSHA-defined standard pass value for sufficient respiratory protection (p < 0.001 for all groups), and so did the lower bound of their 99% CIs (Figure 3). In a total of 138 performed quantitative fit tests with disinfected respirators (0% and 50% relative humidity), none failed the test. In addition, the subjective fit and wearing comfort of the decontaminated respirators did not differ from new masks and were rated 0, or no issues, on the CSA Comfort Assessment Score.
Further, we tested the particle filtration efficiency and breathing resistance in the same 4 types of commercially available N95 respirators that underwent 5 cycles or 10 cycles of thermal disinfection at 0% and 50% relative humidity, respectively (Figure 3). The disinfected respirators significantly exceeded 95% filtration efficiency after 5 and 10 disinfection cycles (p < 0.001). In addition, the breathing resistance of the same set of disinfected respirators was significantly lower than the maximum tolerable resistance standard of 343.23 Pa for all tested groups (p < 0.001).
Interpretation
Following recent reports that showed the heat sensitivity of SARS-CoV-2, we applied thermal disinfection to 4 common, disposable N95 respirator models.5,8 We found that a single thermal disinfection cycle of 60 minutes at 70°C and 0% relative humidity effectively inactivated SARS-CoV-2 in 4 types of N95 respirators and similarly eliminated E. coli when relative humidity was kept at 50% or higher. Moreover, we found that thermal disinfection did not compromise the physical structure of respirators’ electret filter media; nor did it compromise fit, filtration performance, breathing resistance or wearing comfort of the respirators for at least 10 cycles of thermal disinfection at 0% and 50% relative humidity.
Given the high demand for PPE during the COVID-19 pandemic, front-line workers are often instructed to reuse disposable N95 respirators.4,18 Strategies to disinfect and redistribute personalized N95 respirators would increase the safety of health care workers and mitigate depletion of the supply. However, until now, a safe and universally available large-scale decontamination protocol for N95 respirators was not available.
To effectively cope with the global supply shortage, strategies for disinfection and reuse require widespread scale-up. The US Food and Drug Administration recently issued emergency use authorizations for the vapourized hydrogen peroxide gas sterilization of disposable N95 respirators.21,22 Vapourized hydrogen peroxide exposure inactivates SARS-CoV-2 and other pathogens in N95 respirators and maintains their quantitative fit for at least 3 decontamination cycles.23,24 However, this technology is limited to noncellulose–based respirators, therefore making a large proportion of N95s ineligible for reprocessing, and is also unavailable in most hospitals and other facilities.25 Thermal disinfection can be performed at low cost in conventional mechanical convection ovens, which are widely available in commercial kitchens, laboratories or sterilization facilities. Their large capacity enables the simultaneous disinfection of thousands of masks per oven per day, allowing for the process to potentially be scaled to a level sufficient to expand the supply of PPE globally. Thermal disinfection may thereby provide a feasible solution for selected low- and middle-income regions with limited access to PPE and limited testing capacities, helping to protect their front-line personnel during the COVID-19 pandemic.
In agreement with our findings, a recent report shows inactivation of SARS-CoV-2 in N95 respirators after 60 minutes’ exposure to 70°C dry heat.23 Others have shown that shorter thermal disinfection protocols (15 to 40 min at 75°C to 100°C and 0% to 100% relative humidity) maintain the fit and filtration of N95 respirators after multiple disinfection cycles, but without testing the viricidal effects of those protocols.26–29
Beyond thermal disinfection, alternative decontamination procedures have been studied, including ultraviolet (UV) light irradiation (250–280 nm), autoclaving or chemical treatments using 70% ethanol or 2% chlorine solutions (some references from non–peer-reviewed preprint).23,28–35 Autoclaving and chemical treatments have been shown to rapidly degrade filtration efficiency of N95 respirators and are therefore ineligible for clinical use.23,28,34–36 In contrast, UV light decontamination systems may represent a promising approach as they seem to maintain respirator function and inactivate SARS-CoV-2.23,33 However, the scalability of UV decontamination may be limited, as stacking of the masks and consequent shadowing may further impair the limited penetration depth of UV light in porous N95 filter material.28
In conjunction with alternative reprocessing strategies, thermal disinfection can be used as a rapidly applicable emergency measure to alleviate the present global shortage of N95 respirators. Future studies may compare safety, scalability and cost-effectiveness of those decontamination strategies for N95 respirators and specifically investigate SARS-CoV-2 inactivation in respirators contaminated with body fluids such as saliva or blood, to further determine safety in real-world conditions.
Limitations
Owing to the global shortage of N95 respirators, the available sample size was limited in this study. A traditional noninferiority design comparing disinfected to unprocessed masks would require large sample sizes (i.e., 155 masks per group for a fit factor noninferiority limit of 5 at a power of 0.9 and an α of 0.05) or unreasonable wide noninferiority margins. We therefore compared disinfected masks to the OSHA and NIOSH criteria for N95 respirator approval to determine their safety. Further, with respect to caring for patients with COVID-19, N95 respirators may be contaminated with virus-containing body fluids such as blood, potentially necessitating a longer heat exposure for virus inactivation. To account for that, we increased the exposure time to 60 minutes and suggest that visibly contaminated masks not be reprocessed. Another potential limitation of the study is that we did not individually test all components of the respirator (e.g., elastic straps) for complete virus inactivation. However, virus within the tested electret filter media is likely to be relatively resistant to heat disinfection compared with other respirator components, suggesting a low risk for elastic straps or other components to remain infective after thermal disinfection.
Conclusion
Thermal disinfection for 60 minutes at 70°C inactivates SARS-CoV-2; this method uses widely available equipment to enable the safe reuse of disposable N95 respirators without affecting their protective performance. Given the thorough SARS-CoV-2 inactivation and superior bacterial inactivation, we suggest thermal disinfection at 50% relative humidity for up to 10 times. This may provide a feasible, effective and rapidly scalable method for low-tech regions and thereby help to protect front-line workers from job-related risk of infection during the COVID-19 pandemic globally.
Acknowledgements
The authors acknowledge Dianna McCluskey, Ilda Ponte, Lucia Couto and Louis Konstant for their technical assistance with the N95 respirator reprocessing.
Footnotes
Competing interests: No competing interests were declared. This article has been peer reviewed.
Contributors: Simeon Daeschler, Niclas Manson, Gregory Borschel, Jason Maynes and Michelle Science contributed to the conception and design of the work. Simeon Daeschler, Niclas Manson, Paul Chen, Kiana Tajdaran, Kaveh Mirmoeini, Jennifer Zhang, Katelyn Chan, Ali Darbandi, Libo Zhang, Leo Poon and Alex Chin contributed to the data acquisition. Simeon Daeschler and Derek Stephens performed the statistical analysis. Simeon Daeschler, Niclas Manson and Gregory Borschel contributed to the interpretation of the data and drafted the manuscript. All of the authors revised it critically for important intellectual content, gave final approval of the version to be published and agreed to be accountable for all aspects of the work. Simeon Daeschler and Niclas Manson contributed equally to this article.
Funding: Funding was obtained from the Health and Medical Research Fund (COVID190116), Hong Kong and National Institute of Allergy and Infectious Diseases, National Institutes of Health (contract HHSN272201400006C). The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Data sharing: All analyzed data sets are available from the corresponding author (gregory.borschel{at}sickkids.ca) upon reasonable request.
- Accepted July 15, 2020.